National Academies Press: OpenBook
« Previous: Forum Sponsorship and Membership
Suggested Citation:"Timeline." National Academies of Sciences, Engineering, and Medicine. 2021. Forum on Drug Discovery, Development, and Translation: 10 Year Review: 2011-2020. Washington, DC: The National Academies Press. doi: 10.17226/26412.
×
Page 36
Suggested Citation:"Timeline." National Academies of Sciences, Engineering, and Medicine. 2021. Forum on Drug Discovery, Development, and Translation: 10 Year Review: 2011-2020. Washington, DC: The National Academies Press. doi: 10.17226/26412.
×
Page 37
Suggested Citation:"Timeline." National Academies of Sciences, Engineering, and Medicine. 2021. Forum on Drug Discovery, Development, and Translation: 10 Year Review: 2011-2020. Washington, DC: The National Academies Press. doi: 10.17226/26412.
×
Page 38

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

T I M E LI NE 2020 | March 24 Workshop: The Role of Digital Health Workshop 3: Application | July 18 Forum Meeting #40 | Technologies in Drug Development (in collaboration with the October 3–4 Forum Meeting #41 | November 28–29 Workshop: Roundtable on Genomics and Precision Health) | March 25 Virtual Clinical Trials: Challenges and Opportunities Forum Meeting #45 | July 8–9 Forum Meeting #46 | August 5–6 Drug R&D for Adults Across the Older Age Span (in collaboration 2017 | March 8 Workshop: Enabling Precision Medicine: The with the Forum on Aging, Disability, and Independence and the Role of Genetics in Clinical Drug Development (in collaboration National Cancer Policy Forum) | October 29 Forum Meeting #47 with the Roundtable on Genomics and Precision Health) | March 9 Forum Meeting #36 | July 10–11 Forum Meeting #37 2019 | March 6–7 Forum Meeting #42 | March 26 Meeting: | September 19–20 Workshop Series: Examining the Impact Updating Labels for Generic Oncology Drugs (in collaboration of Real-World Evidence on Medical Product Development— with the National Cancer Policy Forum) | July 30–31 Forum Workshop 1: Incentives | October 24–25 Forum Meeting #38 Meeting #43 | September 25–26 Workshop: Enhancing Scientific Reproducibility Through Transparent Reporting (in collaboration 2016 | March 12 Workshop: Deriving Drug Discovery Value with the Forum on Neuroscience and Nervous System Disorders, from Large-Scale Genetic Bioresources (in collaboration with the National Cancer Policy Forum, and the Roundtable on the Roundtable on Genomics and Precision Health) | March 23 Genomics and Precision Health) | October 23–24 Forum Meeting Forum Meeting #33 | July 19–20 Forum Meeting #34 | October #44 | November 18–19 Workshop: Sharing Clinical Trial Data: 18 Forum Meeting #35 | October 19 Workshop: Real-World Challenges and a Way Forward (in collaboration with the Forum Evidence Generation and Evaluation of Therapeutics | December on Neuroscience and Nervous System Disorders, the National 12–13 Workshop: The Drug Development Paradigm in Oncology Cancer Policy Forum, and the Roundtable on Genomics and (in collaboration with the National Cancer Policy Forum) Precision Health) 2015 | January 20–21 Workshop: Financial Incentives to 2018 | March 6–7 Workshop Series: Examining the Impact Support Unmet Medical Needs for Nervous System Disorders of Real-World Evidence on Medical Product Development— (in collaboration with the Forum on Neuroscience and Nervous Workshop 2: Practical Approaches | March 19–20 Forum System Disorders) | March 17–18 Forum Meeting #30 | March Meeting #39 | May 9 Workshop: Advancing the Science of Patient 26–27 Workshop: Rapid Medical Countermeasure Response to Input in Medical Product R&D: Towards a Research Agenda | Infectious Diseases: Enabling Sustainable Capabilities Through July 17–18 Workshop Series: Examining the Impact of Real- Ongoing Public- and Private-Sector Partnerships (in collaboration World Evidence on Medical Product Development— with the Forum on Medical and Public Health Preparedness for 36

Disasters and Emergencies) | June 23–24 Forum Meeting #31 | Second-Line Drugs for Multidrug-Resistant Tuberculosis | October 20 Workshop: Advancing the Discipline of Regulatory October 4–5 Workshop: Sharing Clinical Research Data (in Science for Medical Product Development: An Update on collaboration with the Forum on Neuroscience and Nervous Progress and a Forward-Looking Agenda | October 21 Forum System Disorders, the National Cancer Policy Forum, and the Meeting #32 Roundtable on Genomics and Precision Health) | October 23–24 Forum Meeting #23 | November 26–27 Workshop: Large Simple 2014 | February 12 Workshop: Characterizing and Trials and Knowledge Generation in a Learning Health System Communicating Uncertainty in the Assessment of Benefits (in collaboration with the Leadership Consortium for a Value & and Risks of Pharmaceutical Products (Day 1) | March 3–4 Science-Driven Health System) Forum Meeting #27 | May 12 Workshop: Characterizing and Communicating Uncertainty in the Assessment of Benefits and 2011 | March 28 Forum Meeting #18 | March 29–30 Workshop: Risks of Pharmaceutical Products (Day 2) | June 10–11 Forum Advancing Regulatory Science for Medical Countermeasure Meeting #28 | October 7–8 Forum Meeting #29 Development (in collaboration with the Forum on Medical and Public Health Preparedness for Disasters and Emergencies) | 2013 | January 15 Workshop Summary Release: Developing April 18–19 and 21 Workshop: Facing the Reality of Multidrug- and Strengthening the Global Supply Chain for Second-Line Resistant Tuberculosis: Challenges and Potential Solutions Drugs for Multidrug-Resistant Tuberculosis | January 16–18 (New Delhi, India) | June 27–28 Workshop: Public Engagement Workshop: The Global Crisis of Drug-Resistant Tuberculosis and and Clinical Trials: New Models and Disruptive Technologies Leadership of the BRICS Countries (Beijing, China) | February 12 (in collaboration with the Mount Sinai School of Medicine) | Forum Meeting #24 | February 13–14 Workshop: International June 28–29 Forum Meeting #19 | July 12 Workshop Summary Regulatory Harmonization Amid Globalization of Biomedical Release: The Emerging Threat of Multidrug-Resistant Research and Medical Product Development | June 3 Forum Tuberculosis: Global and Local Challenges and Solutions Meeting #25 | October 28–29 Forum Meeting #26 (Durban, South Africa) | September 20–21 Workshop: Strengthening a Workforce for Innovative Regulatory Science in 2012 | March 13–14 Forum Meeting #21 | June 4–5 Workshop: Therapeutics Development | October 4–5 Forum Meeting #20 | Maximizing the Goals of the Cures Acceleration Network to November 7–8 Workshop: Envisioning a Transformed Clinical Accelerate the Development of New Drugs and Diagnostics Trials Enterprise in the United States: Establishing an Agenda | June 5 Forum Meeting #22 | July 31–August 1 Workshop: for 2020 | November 15 Workshop Summary Release: The Developing and Strengthening the Global Supply Chain for New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective (Moscow, Russia) 37

T I M E LI NE 2010 | February 23 Workshop: The Public Health Emergency Models: Drug Development for Rare and Neglected Diseases Medical Countermeasures Enterprise (in collaboration with the and Individualized Therapies | June 24 Forum Meeting Forum on Medical and Public Health Preparedness for Disasters #10 | October 24 Workshop: Assessing and Accelerating and Emergencies) | February 26 Workshop: Building a National Development of Biomarkers for Drug Safety | November 2–3 Framework for the Establishment of Regulatory Science for Drug Forum Meeting #11 | November 5 Workshop: Addressing the Development | March 3–4 Workshop: The Emerging Threat of Threat of Drug-Resistant Tuberculosis: A Realistic Assessment Multidrug-Resistant Tuberculosis (Pretoria, South Africa) | of the Challenge April 29–30 Forum Meeting #15 | May 26–27 Workshop: The New Profile of Drug-Resistant Tuberculosis (Moscow, Russia) | 2007 | March 12 Symposium: The Future of Drug Safety: August 5 Forum Meeting #16: Conflict of Interest | October 29 Challenges for FDA | April 23–24 Workshop: Emerging Safety Forum Meeting #17: Administrative and Regulatory Inefficiencies Science | April 24 Forum Meeting #7 | September 14 Discussion in Clinical Trials Series: From Patient Needs to New Drug Therapies: Can We Improve the Pathway? | October 15–16 Forum Meeting #8 | 2009 | February 23 Capitol Hill Briefing: Growing Threat of November 30 Discussion Series: A Conversation with Tony Fauci Drug-Resistant Tuberculosis | March 13 Discussion Series: FDA Community Update on Personalized Medicine and the Genetic 2006 | March 28–29 Forum Meeting #4 | May 30–31 Workshop: Basis of Adverse Events | April 27 Workshop: Streamlining Understanding the Benefits and Risks of Pharmaceuticals | Clinical Trial and Material Transfer Negotiations | April 27–28 June 13 Workshop: Addressing the Barriers to Pediatric Drug Forum Meeting #12 | July 10 Symposium: Drug Regulation with Development | June 27–28 Forum Meeting #5 | October 24–25 FDA Commissioner Peggy Hamburg and Forum Meeting #13 Forum Meeting #6 | September 2 Discussion Series: FDA Community Update: Improving the Science of Drug Safety | October 7–8 Workshop: 2005 | March 23–24 Forum Meeting #1 | June 29–30 Forum Transforming Clinical Research in the United States | October Meeting #2 | September 8–9 Forum Meeting #3 | November 15–16 Forum Meeting #14 3–4 Workshop: Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals 2008 | February 20 Discussion Series: Comparative Effectiveness | February 20–21 Forum Meeting #9 | April 21 2002–2004 | Clinical Research Roundtable, predecessor to Discussion Series: Science at FDA: Challenges and the forum Opportunities | June 23 Workshop: Breakthrough Business 38

Next: Forum Staff »
Forum on Drug Discovery, Development, and Translation: 10 Year Review: 2011-2020 Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

This special edition Ten-Year Review takes a look back at some of the most influential work of the National Academies' Forum on Drug Discovery, Development, and Translation over the past decade. In November 2011, amid growing concerns about the future of the U.S. clinical trials enterprise and its competitiveness on the global stage, the forum convened a public workshop for stakeholders to lay out a vision for a transformed clinical trials enterprise in the United States by 2020. This workshop laid the foundation for a variety of forum activities focused on the following thematic priorities:

  • Innovation and the Drug R&D Enterprise
  • Science Across the Biomedical Research Lifecycle
  • Clinical Trials and Medical Product Development
  • Infrastructure and Workforce
  • Patient Engagement and Inclusivity

For more information, please visit the Forum's webpage.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!